Correlation Between Paratek Pharmaceuticals and Sangamo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Paratek Pharmaceuticals and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Paratek Pharmaceuticals and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Paratek Pharmaceuticals and Sangamo Therapeutics, you can compare the effects of market volatilities on Paratek Pharmaceuticals and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Paratek Pharmaceuticals with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Paratek Pharmaceuticals and Sangamo Therapeutics.

Diversification Opportunities for Paratek Pharmaceuticals and Sangamo Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Paratek and Sangamo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Paratek Pharmaceuticals and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and Paratek Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Paratek Pharmaceuticals are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of Paratek Pharmaceuticals i.e., Paratek Pharmaceuticals and Sangamo Therapeutics go up and down completely randomly.

Pair Corralation between Paratek Pharmaceuticals and Sangamo Therapeutics

If you would invest (100.00) in Paratek Pharmaceuticals on November 29, 2024 and sell it today you would earn a total of  100.00  from holding Paratek Pharmaceuticals or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Paratek Pharmaceuticals  vs.  Sangamo Therapeutics

 Performance 
       Timeline  
Paratek Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Paratek Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Paratek Pharmaceuticals is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
Sangamo Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Sangamo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Paratek Pharmaceuticals and Sangamo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Paratek Pharmaceuticals and Sangamo Therapeutics

The main advantage of trading using opposite Paratek Pharmaceuticals and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Paratek Pharmaceuticals position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.
The idea behind Paratek Pharmaceuticals and Sangamo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Directory
Find actively traded commodities issued by global exchanges